Uncertainty did not stop health systems from racing ahead with accountable care as the U.S. Supreme Court debated the healthcare reform law that launched Medicare's efforts to encourage the emerging model.
Now that the law survived largely intact, the industry's accountable care experimentation will give efforts structure and momentum, executives said.
Read the full story: http://tinyurl.com/6o8gosk
Source: ModernHealthcare.com
“We are pleased that the Supreme Court has released their decision because now we know the context in which we move forward,” Chuck Mooty, interim CEO for Minneapolis-based Fairview Health Services, said in a statement.
Long-Term Lebrikizumab Provides Sustained Skin Clearance in Atopic Dermatitis
August 5th 2025In this subanalysis of data from the ADjoin trial of lebrikizumab, the interleukin-13 receptor inhibitor that is also a monoclonal antibody showed itself to be effective over the long term in patients with atopic dermatitis on maintenance therapy.
Read More
A meta-analysis showed that control group outcomes in psilocybin trials for depression were significantly weaker than those in selective serotonin reuptake inhibitor (SSRI) and esketamine trials, suggesting that psilocybin’s large observed treatment effects may be inflated by methodological factors such as functional unblinding and expectancy bias.
Read More
Bridging the Gaps: New Strategies for Preventing Cardiovascular Disease
July 31st 2025During the Addressing Cardiovascular Risk and Intervening Early webinar, experts discussed innovative strategies for cardiovascular disease prevention, emphasizing risk assessment, lifestyle changes, and collaborative care to improve patient outcomes.
Read More